<DOC>
	<DOCNO>NCT00698139</DOCNO>
	<brief_summary>Many patient heart failure unable increase heart rate appropriately body need increase blood flow . As result , may unable mobilize excess fluid body retain . We hypothesize provide assistance body mobilize fluid artificially increase heart rate use pacemaker . We plan conduct prospective clinical trial evaluate hypothesis . We use cross design study patient already biventricular pacemaker implant narrow QRS volume overload . We screen use blood test rough estimate volume overload . Patients meet inclusion criterion randomly assign pacemaker adjust intervention first 2 visit . They unaware group . Following adjustment , monitor six hour . Prior pacemaker adjustment , several test perform evaluate heart function level hormone relate affected heart failure . These test repeat end six hour intervention period visit . At end visit patient pacemaker adjust reset original setting .</brief_summary>
	<brief_title>Cardiovascular Neurohormonal Effects Faster Atrial Pacing Rate</brief_title>
	<detailed_description>Many patient heart failure suffer chronotropic incompetence , inability raise heart rate response metabolic demand . Previous study show brief increase pace rate patient biventricular pacemaker improve cardiac contractility . We hypothesize benefit increase biventricular pacing rate could sustain would improve cardiovascular neurohormonal parameter patient suffer volume overload . We intend prospectively evaluate hypothesis single blind randomized cross-over design trial . We screen 40 patient previously implant biventricular pacemaker ( narrow QRS ) elevate B-type Natriuretic Peptide ( BNP ) level . Following enrollment , patient randomly assign atrial pace rate increase 85 beat per minute unchanged first 2 visit . Patients unaware treatment assignment . They observe six hour monitor set . The primary outcome cardiac output , measure noninvasively NICOM ( Cheetah Medical Inc. , Israel ) system observation period . Secondary outcome include change neurohormonal measure thoracic impedance . If proof-of-concept study demonstrate positive effect , future research would evaluate ability increase pacing rate prevent abort decompensation Congestive Heart Failure ( CHF ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Age &gt; 18 2 . Congestive Heart Failure ( CHF ) ( &gt; 6 month duration ) 3 . Left Ventricular Ejection Fraction ( LVEF ) &lt; 40 % 4 . Functional Class IIIII 5 . Stable oral treatment ( &gt; 1 month ) , 6 . Implanted Medtronic pacemaker/defibrillator ) atrial pace lead biventricular lead , b ) atrial pace lead single ventricular lead patient narrow ( normal ) QRS complex ( &lt; 120 msec ) thus clinical indication biventricular pacing . 7 . Low heart rate ( HR ) ( sinus rhythm ( SR ) atrial pace &lt; 70 bpm ) 8 . Symptomatically stable ( clinical requirement adjustment medical therapy , i.e . diuretic ) 9 . Increase intrathoracic fluid evidence rain natriuretic peptide ( BNP ) &gt; 200 . Exclusion criterion : 1 . Atrial fibrillation 2 . Stable unstable angina 3 . Myocardial infarction within 6 month study 4 . Intravenous inotropic support 5 . Pregnant breast feed woman . Women child bear potential must negative serum pregnancy test prior enrollment . 6 . Severe renal failure ( creatinine &gt; 2.5 mg/dl , hemodyalisis peritoneal dialysis ) 7 . Known hepatic impairment ( total bilirubin &gt; 3 mg/dL , albumin &lt; 2.8 mg/dL , increase ammonia level perform ) 8 . Hemoglobin ( hgb ) &lt; 8 mg % , active bleeding require transfusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>heart failure</keyword>
	<keyword>chronotropic incompetence</keyword>
</DOC>